Physician profile
Henry C Patrick
NPI 1780685917
$3,910.88
in general payments reported to CMS, 2019-2025
28 companies · $434 in 2025
The $434 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $286 · 2020: $374 · 2021: $406 · 2022: $706 · 2023: $905 · 2024: $800 · 2025: $434.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,139.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,139.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $363.05 | 2019-2025 | Repatha |
| Shockwave Medical, INC | $348.19 | 2022-2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Alnylam Pharmaceuticals INC. | $311.78 | 2022-2025 | Onpattro |
| Pfizer INC. | $284.61 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $274.38 | 2021-2025 | |
| Biosense Webster, INC. | $272.71 | 2024 | Qdot Micro Catheter |
| Medtronic Vascular, INC. | $242.00 | 2019-2020 | |
| Medtronic, INC. | $232.75 | 2021-2025 | Cobalt Dr Mri Surescan, Evera Mri Xt Dr Surescan, Linq II |
| Abiomed | $197.30 | 2023-2025 | Impella |
| Esperion Therapeutics, INC. | $189.86 | 2021-2025 | Nexletol |
| Abbott Laboratories | $169.96 | 2022-2025 | Cardiomems |
| Janssen Pharmaceuticals, INC | $139.96 | 2019-2023 | Xarelto |
| E.R. Squibb & Sons, L.L.C. | $127.06 | 2019-2025 | Eliquis, Camzyos |
| Irhythm Technologies, INC. | $125.60 | 2022-2024 | Zio Xt Patch, Zio Monitor |
| Kestra Medical Technology Services, INC. | $95.12 | 2023-2025 | Assure Wcd |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $75.87 | 2024-2025 | Bodyguardian, Cds - Mct/Cem Monitoring |
| Arbor Pharmaceuticals, INC. | $65.66 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $63.45 | 2022-2024 | Wainua, Farxiga |
| Boehringer Ingelheim Pharmaceuticals, INC. | $48.71 | 2023-2024 | Jardiance |
| Baxter Healthcare | $48.55 | 2023 | Hillrom - Carnation Ambulatory Monitor |
| Biotronik INC. | $38.00 | 2024 | Biomonitor |
| Lexicon Pharmaceuticals, INC. | $36.64 | 2023 | Inpefa |
| Kiniksa Pharmaceuticals International, Plc | $36.25 | 2024 | Arcalyst |
| Itamar Medical INC | $32.99 | 2025 | Watchpatone |
| Smith+Nephew, INC. | $31.57 | 2023 | Bone Anchors With Arthroscopic Delivery System, Healicoil, Coblation |
| Merck Sharp & Dohme LLC | $25.66 | 2022-2023 | Verquvo |
| Scpharmaceuticals INC. | $16.73 | 2024 | |
| Novo Nordisk INC | $16.47 | 2025 | Wegovy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Henry Patrick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.